Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBT (2016 - 2025)

cbdMD's EBT history spans 10 years, with the latest figure at -$283131.0 for Q4 2025.

  • On a quarterly basis, EBT fell 1975.66% to -$283131.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a 13.0% increase, with the full-year FY2025 number at -$2.0 million, up 44.84% from a year prior.
  • EBT hit -$283131.0 in Q4 2025 for cbdMD, up from -$679968.0 in the prior quarter.
  • Over the last five years, EBT for YCBD hit a ceiling of $1.6 million in Q2 2021 and a floor of -$31.6 million in Q2 2022.
  • Historically, EBT has averaged -$5.7 million across 5 years, with a median of -$1.6 million in 2023.
  • Biggest five-year swings in EBT: tumbled 2028.57% in 2022 and later surged 125.97% in 2024.
  • Tracing YCBD's EBT over 5 years: stood at -$19.2 million in 2021, then skyrocketed by 79.35% to -$4.0 million in 2022, then skyrocketed by 74.81% to -$996501.0 in 2023, then surged by 101.51% to $15095.0 in 2024, then crashed by 1975.66% to -$283131.0 in 2025.
  • Business Quant data shows EBT for YCBD at -$283131.0 in Q4 2025, -$679968.0 in Q3 2025, and -$895272.0 in Q2 2025.